Antispasm Anticholinergics
PDL Status Values
Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the
Non-Preferred Drugs in Select PDL Classes prior authorization criteria.
New drugs will be listed as N until reviewed by the P&T Committee and are subject to the
New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.
To request a Prior Authorization, please use this form.
Generic Name | Brand Name | Form | PDL Status |
Current Drug Use Criteria | New Drug Evaluation |
---|---|---|---|---|---|
atropine sulfate | ATROPINE SULFATE | SYRINGE | |||
atropine sulfate | ATROPINE SULFATE | VIAL | |||
dicyclomine HCl | BENTYL | AMPUL | |||
dicyclomine HCl | DICYCLOMINE HCL | AMPUL | |||
dicyclomine HCl | DICYCLOMINE HCL | CAPSULE | |||
dicyclomine HCl | DICYCLOMINE HCL | SOLUTION | |||
dicyclomine HCl | DICYCLOMINE HCL | TABLET | |||
dicyclomine HCl | DICYCLOMINE HCL | VIAL | |||
glycopyrrolate | CUVPOSA | SOLUTION | |||
glycopyrrolate | GLYCOPYRROLATE | SOLUTION | |||
glycopyrrolate | DARTISLA | TAB RAPDIS | |||
glycopyrrolate | GLYCATE | TABLET | |||
glycopyrrolate | GLYCOPYRROLATE | TABLET | |||
glycopyrrolate | ROBINUL | TABLET | |||
glycopyrrolate | ROBINUL FORTE | TABLET | |||
glycopyrrolate | GLYCOPYRROLATE | VIAL | |||
glycopyrrolate in water/PF | GLYCOPYRROLATE | SYRINGE | |||
glycopyrrolate/PF | GLYCOPYRROLATE | SYRINGE | |||
glycopyrrolate/PF | GLYRX-PF | SYRINGE | |||
glycopyrrolate/PF | GLYRX-PF | VIAL | |||
methscopolamine bromide | METHSCOPOLAMINE BROMIDE | TABLET | |||
phenobarb/hyoscy/atropine/scop | ANTISPASMODIC | ELIXIR | |||
phenobarb/hyoscy/atropine/scop | BELLADONNA W/PHENOBARBITAL | TABLET | |||
phenobarb/hyoscy/atropine/scop | PHENOHYTRO | TABLET | |||
propantheline bromide | PROPANTHELINE BROMIDE | TABLET | |||
propantheline bromide | PRO-BANTHINE | TABLET |